识别45岁及以下子宫内膜增生或癌症风险升高的女性
本研究基于美国多医院系统2016至2019年数据,回顾性分析3175例18-45岁异常子宫出血并接受子宫内膜取样的患者,采用多变量泊松回归识别与子宫内膜增生和/或癌症(EH/EC)相关的因素。结果显示BMI和PCOS与EH/EC风险升高相关,非西班牙裔黑人种族与风险降低相关;EH/EC患病率从BMI<25的2%到BMI≥50的16%(p-trend<0.001)。结合风险因素组合后,预测概率最高达34-36%。
要点
- BMI和PCOS与EH/EC风险升高相关,非西班牙裔黑人种族与风险降低相关。
- EH/EC患病率随BMI升高而增加,从BMI<25的2%到BMI≥50的16%(p-trend<0.001)。
- 合并PCOS、糖尿病、BMI≥50及西班牙裔或亚裔/其他/未知种族的患者预测概率最高,为34-36%。
核心结论
- 在45岁及以下异常子宫出血患者中,结合关键风险因素组合后,EH/EC风险范围广泛;本文提供的更细致的风险估计有助于为该人群子宫内膜取样临床决策提供信息。
研究设计与样本
- 回顾性队列研究,纳入2016至2019年在美国多医院系统内因异常子宫出血接受子宫内膜取样的18-45岁患者,共3175例。
- 采用账单代码查询识别患者,使用多变量泊松回归识别与EH/EC相关的因素,并计算按因素分层的患病率及特征组合下的预测概率。
主要发现
- 中位年龄39岁(四分位距[IQR]:35-43),BMI为29.7 kg/m2(IQR:24.2-36.9)。
- 39%为非西班牙裔白人,41%为非西班牙裔黑人,9%为西班牙裔,11%为亚裔/其他/未知。
- BMI和PCOS与EH/EC风险升高相关;非西班牙裔黑人种族与风险降低相关。
- EH/EC患病率从BMI<25的2%到BMI≥50的16%(p-trend<0.001)。
- 患病率估计因种族/民族而异:非西班牙裔黑人患者最低(BMI<25为0.5% vs BMI≥50为9%),西班牙裔患者最高(BMI<25为1.5% vs BMI≥50为33%)。
关键数值与推荐
- 合并PCOS、糖尿病、BMI≥50以及西班牙裔或亚裔/其他/未知种族的患者预测概率最高,为34-36%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the prevalence of, and identify risk factors associated with, endometrial hyperplasia and/or cancer (EH/EC) in patients ≤45 years old undergoing endometrial sampling for abnormal uterine bleeding (AUB). METHODS: We performed a retrospective cohort study of patients 18-45 years old with AUB who underwent endometrial sampling between 2016 and 2019 within a US-based multi-hospital system using billing code queries. We used multivariable Poisson regression to identify factors associated with EH/EC and calculated prevalence stratified by these factors. We estimated predicted probabilities within combinations of characteristics in order to examine the range of risk in this population. RESULTS: Among 3175 patients, median age was 39 years (interquartile range [IQR]:35-43) and BMI was 29.7 kg/m2 (IQR: 24.2-36.9). Thirty-nine percent were non-Hispanic White, 41% non-Hispanic Black, 9% Hispanic, and 11% Asian/Other/Unknown. BMI and polycystic ovarian syndrome (PCOS) were associated with higher EH/EC risk; non-Hispanic Black race was associated with lower risk. EH/EC prevalence ranged from 2% in BMI <25 to 16% in BMI ≥50 kg/m2 (p-trend <0.001). These prevalence estimates differed by race/ethnicity with the lowest estimates in non-Hispanic Black patients (0.5% BMI <25 vs. 9% BMI ≥50) and highest in Hispanic patients (1.5% BMI <25 vs. 33% BMI ≥50). Accounting for combinations of risk factors, predicted probabilities were highest - 34-36% - among patients with PCOS, diabetes, BMI ≥50, and Hispanic or Asian/Other/Unknown race/ethnicity. CONCLUSIONS: When accounting for combinations of key risk factors, risk of EH/EC in patients ≤45 years old with AUB ranges widely; the more nuanced estimates of risk presented here could help inform clinical decision-making about endometrial sampling in this population.
引用
- Beavis AL, Blechter B, Najjar O, et al. Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer. Gynecol Oncol. 2023. PMID: 37172411. doi:10.1016/j.ygyno.2023.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。